MDxHealth (MDXH) Common Equity (2020 - 2026)

MDxHealth has reported Common Equity for 8 years, with the latest figure at -$20.2 million in Q1 2026.

• Quarterly Common Equity fell 438.96% year-over-year to -$20.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$20.2 million (down 438.96% YoY) and the FY2025 annual result came in at -$12.1 million, down 181.49% from the prior year.
• Common Equity fell to -$20.2 million in Q1 2026 per MDXH's latest filing, from -$12.1 million in the prior quarter.
• Over five years, Common Equity peaked at $9.0 billion in Q2 2025 and troughed at -$20.2 million in Q1 2026.
• A 5-year average of $607.0 million and a median of $9.3 million in 2022 frame the typical range for Common Equity.
• The sharpest annual moves came in 2025 and 2026: Common Equity soared 102290.2% in 2025, then sank 438.96% in 2026.
• Over 5 years, Common Equity stood at $9.3 million in 2022, then retreated by 22.62% to $7.2 million in 2023, then soared by 105.9% to $14.8 million in 2024, then slumped by 181.49% to -$12.1 million in 2025, then slumped by 67.26% to -$20.2 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered -$20.2 million, -$12.1 million, and -$8.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.